Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies

Date: September 29, 2025

Journal: JAMA

Citation: Chambers JD, Rucker JA, Enright DE, Beinfeld MT, Neumann PJ. Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies. JAMA. 2025 Sep 29:e2515148. doi: 10.1001/jama.2025.15148. Epub ahead of print. PMID: 41021246; PMCID: PMC12481358.

This Viewpoint examines variations in US commercial health plan coverage restrictions for cell and gene therapies.

Read Original Publication

More Publications

Bereavement Experiences Among Parents of Children With Spinal Muscular Atrophy Type 1

View Publication

Family spillover effects in cost-effectiveness analyses of vaccines

View Publication

Characterizing financial risk from out-of-pocket expenditures across dementia stages

View Publication

View All Publications